Introduction to Psychedelic-assisted Therapy
The Introduction to Psychedelic-assisted Therapy is a continuing education credited training course designed for practising psychologists, psychiatrists, and other medical professionals. The course is a prerequisite for the ATMA Advanced Psychedelic-assisted Therapy (PaT) Certification Program, and
Course Overview
The Introduction to Psychedelic-assisted Therapy is a continuing education credited training course designed for practising psychologists, psychiatrists, and other medical professionals. The course is a prerequisite for the ATMA Advanced Psychedelic-assisted Therapy (PaT) Certification Program, and is accepting registrations every second month.
The course begins by redefining the psychiatric model from one of "chemical imbalance" to one rooted in the mind-body-spirit dynamic, and provides historical context for the development of psychedelic medicines. The didactic course material will cover various psychedelic medicines currently in use, including an emphasis on psilocybin, MDMA, LSD, iboga, ayahuasca, and ketamine. The course will also explore how psychedelic-assisted therapy can be integrated into and enhance existing therapeutic modalities, such as internal family systems (IFS), cognitive-behavioural therapy (CBT), somatic therapy, and eye movement desensitization and reprocessing (EMDR).
The program includes 12 lessons, 17 hours of video lectures, 4 hours of interactive Q&A, community platform membership and CE credits (valid in Canada). The training is designed to provide evidence-based tools to enhance current practice for practising social workers, counsellors, psychologists, psychiatrists and medical professionals.
Who is this for?
practising psychologists, psychiatrists, and other medical professionals
Prerequisites
Prerequisite for the ATMA Advanced Psychedelic-assisted Therapy (PaT) Certification Program
About the Provider
ATMA Journey Centers is an Alberta-based Canadian pioneer in psychedelic-assisted therapy, operating clinically supervised locations across Canada while offering comprehensive psychedelic-assisted therapy training programs (ATMA CENA) covering psilocybin, MDMA, and ketamine for healthcare professionals. With 740+ training alumni and 800+ community members, ATMA also operates a clinic network partnership program and Phase II psilocybin clinical trials with Health Canada approval.
View Atma Journey profileCourse Details
- Price$1,600
- FormatLive Classes
- Lifecycle statusNo New Dates
- Skillsevidence-based toolspsychedelic therapymind-body-spirit dynamicpsychiatric modelpsychedelic medicinestherapeutic modalitiesinternal family systemscognitive-behavioral therapysomatic therapyeye movement desensitizationreprocessingPsychedelic-assisted therapyPsychiatric model redefinitionIntegration of therapeutic modalities
- Categories
You will be redirected to the provider's website
Related Courses
View all coursesAdd Spravato® To Your Practice with our 8-Phases Implementation Roadmap
Spravato FastTrack is an implementation course for clinics that want to add Spravato (esketamine) services. It covers REMS certification, procurement, prior authorization, billing, documentation, and related operational steps.
Automated status check: No valid upcoming cohort date found on the source page (checked 2026-04-15).
Certificate in Psychedelic-Assisted Therapies & Research | CIISCIIS LogoCIIS Logo
A 12-month certificate in psychedelic-assisted therapies and research offered by CIIS. The program includes hybrid or online study and covers clinical competencies, research, cultural context, and ethical practice.
Curriculum
A curriculum focused on psilocybin, MDMA, and ketamine facilitation for spiritual and psychotherapeutic care. It was grounded in inclusion, reciprocity, and respect, and combined scientific, ancestral, and communal perspectives.
Automated status check: No valid upcoming cohort date found on the source page (checked 2026-04-15).